Related references
Note: Only part of the references are listed.Thioredoxin Binding Protein 2 Modulates Natural Killer T Cell-Dependent Innate Immunity in the Liver: Possible Link to Lipid Metabolism
Hiroaki Okuyama et al.
ANTIOXIDANTS & REDOX SIGNALING (2009)
MCD-induced steatohepatitis is associated with hepatic adiponectin resistance and adipogenic transformation of hepatocytes
Claire Z. Larter et al.
JOURNAL OF HEPATOLOGY (2008)
Isoprostanes and hepatic fibrosis
Mario Comporti et al.
MOLECULAR ASPECTS OF MEDICINE (2008)
Mitochondrial involvement in non-alcoholic steatohepatitis
Gaetano Serviddio et al.
MOLECULAR ASPECTS OF MEDICINE (2008)
Methionine deficiency and hepatic injury in a dietary steatohepatitis model
Helieh S. Oz et al.
DIGESTIVE DISEASES AND SCIENCES (2008)
Thioredoxin and thioredoxin-binding protein-2 in cancer and metabolic syndrome
Ahsan M. Kaimul et al.
FREE RADICAL BIOLOGY AND MEDICINE (2007)
Regulation of the bioavailability of thioredoxin in the lens by a specific thioredoxin-binding protein (TBP-2)
Narnal P. M. Liyanage et al.
EXPERIMENTAL EYE RESEARCH (2007)
CCAAT/enhancing binding protein β deletion in mice attenuates inflammation, endoplasmic reticulum stress, and lipid accumulation in diet-induced nonalcoholic steatohepatitis
Shaikh Mizanoor Rahman et al.
HEPATOLOGY (2007)
Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis
Kanji Yamaguchi et al.
HEPATOLOGY (2007)
Extracellular thioredoxin and thioredoxin-binding protein 2 in control of cancer
Hajime Nakamura et al.
SEMINARS IN CANCER BIOLOGY (2006)
Effects of bezafibrate, PPAR pan-agonist, and GW501516, PPARδ agonist, on development of steatohepatitis in mice fed a methionine- and choline-deficient diet
T Nagasawa et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
COX-2 induction in mice with experimental nutritional steatohepatitis:: Role as pro-inflammatory mediator
J Yu et al.
HEPATOLOGY (2006)
Loss of interleukin-2-dependency in HTLV-I-infected T cells on gene silencing of thioredoxin-binding protein-2
MK Ahsan et al.
ONCOGENE (2006)
Identification and characterization of a mammalian 39-kDa poly(ADP-ribose) glycohydrolase
S Oka et al.
FASEB JOURNAL (2006)
Non-alcoholic steatohepatitis: From cell biology to clinical practice
H Cortez-Pinto et al.
JOURNAL OF HEPATOLOGY (2006)
Glutathione-enhancing agents protect against steatohepatitis in a dietary model
HS Oz et al.
JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY (2006)
Thioredoxin-1 suppresses lung injury and apoptosis induced by diesel exhaust particles (DEP) by scavenging reactive oxygen species and by inhibiting DEP-induced downregulation of Akt
MK Ahsan et al.
FREE RADICAL BIOLOGY AND MEDICINE (2005)
Oxidative stress augments the production of matrix metalloproteinase-1, cyclooxygenase-2, and prostaglandin E2 through enhancement of NF-κB activity in lipopolysaccharide-activated human primary monocytes
YB Lu et al.
JOURNAL OF IMMUNOLOGY (2005)
VDUP1 is required for the development of natural killer cells
KN Lee et al.
IMMUNITY (2005)
Loss of thioredoxin-binding protein-2/vitamin D3 up-regulated protein 1 in human T-cell leukemia virus type I-dependent T-Cell transformation: Implications for adult T-Cell leukemia leukemogenesis
Y Nishinaka et al.
CANCER RESEARCH (2004)
Increased lipogenesis and fatty acid reesterification contribute to hepatic triacylglycerol stores in hyperlipidernic Txnip-/- mice
KL Donnelly et al.
JOURNAL OF NUTRITION (2004)
TGF-β isoforms in renal fibrogenesis
L Yu et al.
KIDNEY INTERNATIONAL (2003)
Central role of PPARα-dependent hepatic lipid turnover in dietary steatohepatitis in mice
E Ip et al.
HEPATOLOGY (2003)
VDUP1 upregulated by TGF-β1 and 1,25-dihydorxyvitamin D3 inhibits tumor cell growth by blocking cell-cycle progression
SH Han et al.
ONCOGENE (2003)
Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome
G Marchesini et al.
HEPATOLOGY (2003)
Vitamin D-3 up-regulated protein-1 regulates collagen expression in mesangial cells
T Kobayashi et al.
KIDNEY INTERNATIONAL (2003)
Lipid peroxidation, stellate cell activation and hepatic fibrogenesis in a rat model of chronic steatohepatitis
J George et al.
JOURNAL OF HEPATOLOGY (2003)
The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin
LM Butler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: Further evidence for an etiologic association
G Pagano et al.
HEPATOLOGY (2002)
Non-alcoholic fatty liver disease
P Angulo et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2002)
Positional cloning of the combined hyperlipidemia gene Hyplip1
JS Bodnar et al.
NATURE GENETICS (2002)
The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity
T Yamauchi et al.
NATURE MEDICINE (2001)
Chronic elevation of plasma thioredoxin: Inhibition of chemotaxis and curtailment of life expectancy in AIDS
H Nakamura et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Vitamin D3 up-regulated protein 1 mediates oxidative stress via suppressing the thioredoxin function
E Junn et al.
JOURNAL OF IMMUNOLOGY (2000)
Dietary choline restriction causes complex I dysfunction and increased H2O2 generation in liver mitochondria
K Hensley et al.
CARCINOGENESIS (2000)
Share Paper
